$550,000 grant supports VT researchers to study the effects of changing food spending patterns

After a long day, there’s the age-old question of do we eat out or stay in? Over the last decade, that answer has increasingly shifted to eating out.

Kymera’s stock rises after derma investigation expands; Ligand buys Apeiron

Plus, news about AEON Biopharma, Moderna and Mitsubishi Tanabe: Sanofi expands dermatology trials: Kymera Therapeutics said that expanding the Phase … Sign up to read

July 10, 2024

What Do We Know About the EU.1.1 COVID Variant?

The CDC is tracking a handful of new COVID variants, including the EU.1.1 variant, which now makes up an estimated 1.7% of U.S. COVID cases.

June 28, 2023

Awakn Life Sciences Completes Successful Investigative Study to Establish Dissociative Effect of a Proprietary Sublingual S-Ketamine Oral Thin Film Formulation in Harmful Drinkers | Psychedelic Invest

Awakn Life Sciences Corp. (CBOE: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn”), a clinical-stage biotechnology company developing medication-assisted treatments for addiction with a near-term focus on

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.